Enhanced Antithrombotic Mechanisms in Patients with Maturity-Onset Diabetes mellitus without Thromboembolic Complications

Summary

Some haemostatic parameters have been evaluated in a group of rigorously selected patients with maturity-onset diabetes mellitus without thromboembolic complications and in apparently normal subjects of the same age before and after the venous occlusion test (VOT).

In basal conditions diabetics had higher levels of AT III as biological activity and higher fibrinolytic and antifibrinolytic activities than controls

After VOT, F VIII R:Ag increased significantly in both groups, more markedly in controls than in diabetics, while F VIII: C showed no modification.

Also AT III R:Ag increased after the test, but such variation was significant only in diabetics; on the contrary, the biological activity of AT III was always significantly decreased after the test.

After VOT there were also in both groups highly significant increases in the fibrinolytic and antifibrinolytic activities.

Finally, HbA_1c levels directly correlated with AT III as biological activity before VOT, but with no other parameter either before or after the test.

These data suggest the existence in patients with diabetes mellitus without thromboembolic complications of an activated protective mechanism against intravascular clotting.

Keywords

Antithrombotic mechanisms - Diabetes without thromboembolic complications - Antithrombin III - Plasminogen activator

• References

• 1 Banerjee RN, Sahni AL, Kumar V, Arya M. Antithrombin III deficiency in maturity-onset diabetes mellitus and atherosclerosis. Thrombos Diathes Haemorrh 1974; 31: 339-345
• 2 Gandolfo GM, De AngelisA, Torresi MV. Determination of antithrombin III activities by different methods in diabetic patients. Haemostasis 1980; 9: 15-19
• 3 Corbella E, Miragliotta G, Masperi R, Villa S, Bini A, De Gaetano G, Chiumello G. Platelet aggregation and antithrombin in levels in diabetic children. Haemostasis 1979; 8: 30-37
• 4 Fuller JH, Keen H, Jarrett RJ, Omer T, Meade TW, Chakrabarti R, North WR, Stirling Y. Haemostatic variables associated with diabetes and its complications. Br Med J 1979; 2: 964-966
• 5 Elder GE, Mayne EE, Daly JG, Kennedy AL, Hadden DR, Montgomery DA D, Weaver JA. Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy. Haemostasis 1980; 9: 288-296
• 6 Masperi R, Mussoni L, Bini A, Donati MB, Chiumello G. Haemostatic variables in uncomplicated diabetic children. Thromb Haemostas 1980; 43: 227
• 7 Gensini GF, Abbate R, Favilla S, Neri SerneriG. Changes of platelet function and blood clotting in diabetes mellitus. Thromb Haemostas 1979; 42: 983-993
• 8 Aimer LO, Nilsson IM. On fibrinolysis in diabetes mellitus. Acta Med Scand 1975; 198: 101-106
• 9 Bern MM, Cassani MP, Horton J, Rand L, Davis G. Changes of fibrinolysis and Factor VUE coagulant, antigen and ristocetin cofactor in diabetes mellitus and atherosclerosis. Thromb Res 1980; 19: 831-839
• 10 Gamba G, Grignani G, Montera V, Perotti G, Ragone L, Ascari E. Activators and inhibitors of the fibrinolytic system in maturity-onset diabetes mellitus without thromboembolic manifestations. Unpublished data
• 11 Nilsson IM, Robertson B. Effect of venous occlusion on coagulation and fibrinolytic components in normal subjects. Thrombos Diathes Haemorrh 1968; 20: 397-408
• 12 Laurell C. Quantitative estimation of protein by electrophoresis in agarose gel containing antibodies. Analyt Biochem 1966; 15: 45-52
• 13 Biggs R. Human blood coagulation, haemostasis and thrombosis. Blackwell Scientific Publications 1972; p614
• 14 Bick LR, Kovacs I, Fekete LF. A new two-stage functional assay for antithrombin III (heparin cofactor): clinical and laboratory evaluation. Thromb Res 1976; 8: 745-756
• 15 Nilsson IM, Hedner U, Pandolfi M. The measurement of fibrinolytic activities. IV Fibrin Plate Method in Fibrinolytic and Antifibrinolytic. Markwardt F. (ed.) 112-116 Springer-Verlag; Berlin-Heidelberg-New York: 1978
• 16 Sharrer J, Maas C. Investigations of fibrinolysis in patients with metastasizing tumours. Thromb Haemostas 1979; 42: 219
• 17 Tager-Nilsson AC, Friberger P, Gyzander E. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scan J Clin Lab Invest 1977; 37: 403-409
• 18 Ingram GI C. The determination of plasma fibrinogen by the clot- weight method. Biochem J 1952; 51: 583-585
• 19 Chan TK, Chan V. The effect of venous occlusion on antithrombin III, plasminogen activator and fibrinogen degradation product (fragment E) levels. Thromb Res 1979; 14: 525-534
• 20 Trivelli LA, Ranney HM, Lai HT. Haemoglobin components in patients with diabetes mellitus. N Engl J Med 1971; 284: 353-357
• 21 Ponari O, Civardi E, Meglie A, Pini M, Poti R, Dettori AG. Effect of alpha- and beta-blocking drugs on the clotting and fibrinolytic response to venous stasis in man. Br J Haematol 1973; 24: 463-470
• 22 Giustolisi R, Lombardo T, Musso R, Cacciola E. Factor VIII antigen plasma levels in diabetes mellitus. Enhanced endothelial release and storage Thromb Haemostas 1980; 44: 46
• 23 Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured endothelial cells. J Clin Invest 1973; 52: 2757-2764
• 24 Piovella F, Ricetti MM, Almasio P, Castagnola C, Pesenti Campagnoni M, Gallotti P, Feoli FR, Ascari E. Characterisation and synthesis of some factor VIII related antigen properties in cultured human endothelial cells. Haematologica 1979; 64: 714-724
• 25 Chan V, Chan TK. Antithrombin III in fresh and cultured human endothelial cells: a natural anticoagulant from the vascular endothelium. Thromb Res 1979; 15: 209-213
• 26 Philip JA D, Walker ID, Davidson JF. The ratio of functional immunologic antithrombin III as an index of antithrombin consumption. Thromb Haemostas 1979; 42: 375
• 27 Grignani G, Gamba G, Biancardi M, Geroldi D, Ferrari E, Bossolo PA, Cinquini G, De Marco R. Studies on the prethrombotic state of patients with maturity-onset diabetes mellitus undergoing different hypoglicemic treatments. Thromb Haemostas 1979; 42: 486